Literature DB >> 6434405

Mitogen-induced gamma interferon production in peripheral blood lymphocytes from patients with colorectal tumors.

D S Müller, B Manger, R Zawatzky, H Kirchner, J R Kalden.   

Abstract

Mitogen-induced interferon production in peripheral blood lymphocytes from patients with colorectal tumors was not significantly different from that observed in patients with Crohn's disease and sex- and age-matched controls. In the group of patients with colorectal carcinomas, no correlation was obtained with regard to the interferon titer, the in vivo lymphocyte proliferation and the clinical stage of the disease or tumor staging and grading respectively. Most importantly, the data show that despite an obvious defect in T-lymphocyte proliferation, measurement of lymphokine production in mitogen-stimulated cell cultures was not impaired.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434405     DOI: 10.1016/s0171-2985(84)80026-1

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  4 in total

Review 1.  Production of inflammatory cytokines in the intestinal lamina propria.

Authors:  C Fiocchi
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease.

Authors:  B Y Lieberman; C Fiocchi; K R Youngman; W K Sapatnekar; M R Proffitt
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

3.  Surface phenotypes of human peripheral blood mononuclear cells from patients with gastrointestinal carcinoma.

Authors:  G Boltz; E Penner; C Holzinger; S Bakos; A Fellinger; M Walgram; C Wiltschke; H Rumpold; K Langer; A Gangl
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Plasma glutamate concentration and lymphocyte activity.

Authors:  W Dröge; H P Eck; M Betzler; P Schlag; P Drings; W Ebert
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.